Thanapaul R, Shvedova M, Shin GH, Roh DS
Tamoxifen 10mg is a selective estrogen receptor modulator (SERM) used in hormone-related cancer treatment protocols Commonly prescribed for the treatment and management of hormone receptor-positive breast cancer as advised by oncologists and healthcare professionals Helps block the effects of estrogen on certain breast cancer cells, supporting long-term disease management Frequently used as part of ongoing oncology treatment and follow-up care plans Convenient oral tablet formulation enhances patient compliance and ease of administration Widely prescribed by oncologists, surgical oncologists, and cancer care specialists This strengthens a comprehensive oncology and women's healthcare portfolio
Therefore, the role of GSH-degrading enzymes is key to regulate the cell stress environment
Disclosures: Catherine Mezzacappa: Nothing to Disclose, Pedro Ochoa-Allemant: Nothing to Disclose, Marina Serper: Transplant Genomics: Grant/Research Support, Grifols: Grant/Research Support, Eurofins: Grant/Research Support, Tamar Taddei: Nothing to Disclose, Binu John: Exact Sciences: Grant/Research Support, Genentech: Grant/Research Support, Glycotest, Inc: Grant/Research Support, Gilead: Grant/Research Support, Exelixis: Consultant, Takeda: Grant/Research Support, GlaxoSmithKline: Consultant, Astra Zeneca: Consultant, David Kaplan: AstraZeneca Inc: Grant/Research Support, Roche Genentech: Independent Contractor, Exact Sciences: Grant/Research Support, Glycotest: Grant/Research Support, Sirtex: Advisor, Exelixis: Advisor, AstraZeneca: Advisor, Nadim Mahmud: Nothing to Disclose 1081 THYROID DISORDERS (HYPOTHYRODISM AND HYPERTHYRODISM) AND THEIR ASSOCIATIONS WITH NONALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS: A STUDY ON INPATIENT OUTCOMES, INCIDENCE AND PREVALENCE Anwar Uddin Madia Ahad 1 Rafat Uddin 1 Selome Yewedalsew 1 Prashil Dave 1 Dipsa Shastri 2 Afgal Ahad 1 Rahat Uddin 1 Peter Lymberopoulos 1 Nazeera Ghanie 1 Sahil Chaddha 3 , 1 State University of New York Downstate, 2 East Tennessee State University, 3 SUNY Downstate Medical Center Background: Thyroid disorders are one of most common comorbid conditions present in patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH)
British Journal of Pharmacology (2022) 11
Ceramide analogs : D-threo- 1 -phenyl^-palmitoylamino-S-pyrrolidino- 1 -propanol (P4) or a P4 derivative, like D-threo-4'-hydroxy-l-phenyl-2-palmitoylamino-3- pyrrolidino -1-propanol (4'-hydroxy-P4), D-threo- 1 -(3 ',4'-trimethylenedioxy)phenyl-2- palmitoylami no-3-pyrrolidino- 1-propanol (trimethylenedioxy-P4), D-threo- 1 -(3 ',4'- methylenedioxy)phenyl-2-palmitoylamino- 3-pyrrolidino- 1 -propanol (methylenedioxy- P 4 ) and D-threo- 1 -(3 ',4'-ethylenedioxy)phenyl-2-palmitoylamino-3 -pyrrolidino- 1 - propanol (ethylenedioxy-P4 or D-t-et-P4)
